A treatment refractory CD30-positive diffuse large B cell lymphoma in the ileal neobladder
暂无分享,去创建一个
H. Kaneko | J. Kuroda | M. Ohshiro | Y. Hirakawa | T. Iwai | H. Uchiyama | Y. Chinen | Saeko Ota | T. Fujino | Yuka Kawaji
[1] Shaoying Li,et al. CD30 expression and its correlation with MYC rearrangement in de novo diffuse large B‐cell lymphoma , 2016, European journal of haematology.
[2] R. Gascoyne,et al. CD30 expression in de novo diffuse large B‐cell lymphoma: a population‐based study from British Columbia , 2014, British journal of haematology.
[3] W. Choi,et al. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. , 2013, Blood.
[4] K. Ohshima,et al. Diffuse large B-cell lymphoma arising primarily at the stoma after bladder reconstruction using ileal conduit. , 2012, Internal medicine.
[5] M. Kim,et al. Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] N. Pranesh. Lymphoma in an ileostomy , 2002, Postgraduate medical journal.
[7] J. Rambaud,et al. Primary stomal lymphoma. An unusual complication of ileostomy in a patient with transfusion‐related acquired immune deficiency syndrome , 1990, Cancer.